Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-05-25
1981-11-10
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 12, G01N 2348, G01T 100
Patent
active
042998140
ABSTRACT:
A method is disclosed for detecting the presence of migration inhibitory factor (MIF) which comprises reacting a test solution containing an unknown amount of MIF antigen, a known amount of MIF antigen which has been radiolabeled, a known amount of antibodies to MIF, and thereafter precipitating and removing the resulting immune complex and measuring the radioactive content thereof, said antibodies to MIF being produced by immunization of animals with MIF antigen obtained from the growth of human lymphocytes under tissue culture conditions.
REFERENCES:
Rocklin, J. Immunol., 112, 1461-1466 (1974).
Fox et al., Immunol. Communications, 3, 375-389 (1974).
McLeod et al., Cell. Immunol., 32, 370-384 (1977).
David, Fed. Proc., 30(6), 1730-1735 (1971).
Asculai Samuel S.
Brandt Eva J.
Meyer Scott J.
Monsanto Company
Nucker Christine M.
Padgett Benjamin R.
Williams, Jr. James W.
LandOfFree
Radioimmunoassay of MIF does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioimmunoassay of MIF, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioimmunoassay of MIF will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2362375